TKL Research Opens Research Clinic at the Fair Lawn Promenade

FAIR LAWN, N.J.--TKL Research, a full-service clinical research organization (CRO), is proud to announce the opening of its new research clinic in Fair Lawn, NJ. TKL's largest clinic to date, the Fair Lawn site is unique in the fact that it contains a dorm area for overnight studies as well as multiple examination rooms for outpatient studies. The size and versatility allow TKL to expand on the types of programs that are run, while continuing to focus on its primary goal of testing for the safety and effectiveness of pharmaceutical, consumer health and personal care products as well as medical devices before they are released into the marketplace.

As part of the newly constructed Fair Lawn Promenade, a mixed-use community located on Route 208 North and within walking distance of the Radburn Train Station, TKL has placed its clinic in a very safe and accessible location. "This development offered an ideal opportunity for TKL", said TKL Research President and CEO, Jon C. Anderson, PhD. "We're going to be at the perfect intersection of quality and convenience, all within a short distance to New York City and New Jersey's major thoroughfares."

A local fixture in Bergen County since 1982, TKL has been participating in clinical trials for over fifty years. With a flawless reputation for safety, expertise and professionalism, TKL has continued to expand its reach with multiple clinics throughout the New York metropolitan area and Europe. The Fair Lawn site is the most recent addition to the TKL family.

Due to new programs starting on a regular basis, TKL is always looking for volunteer participants. Each study is unique in duration and amount of participation time. Based on these factors, compensation is given accordingly.

For more information on how to become a potential study volunteer, please call TKL Research at 201.587.0808 or visit tklresearch.com for more information.

About TKL Research, Inc.

TKL Research is a full-service, international CRO offering complete Phase 1-4 clinical trial services, often in enrollment-driven therapeutic areas. The company has a solid reputation for reducing clinical trial timelines by taking responsibility for enrollment and site selection. TKL's experience began in dermatology and now includes allergy/respiratory, diabetes, gastroenterology, women's health, and other therapeutic areas.

 

Contacts

TKL Research, Inc.
Allison Anderson, 201.785.6698
[email protected]

 

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.